Researchers at Texas A&M are testing smart catheter sensors for early diagnosis and treatment of UTIs to lower the risk of patient complications.

Researchers are developing emergency injectable bandages that could decrease bleeding time by as much as 70% and revolutionize the future of trauma care.

Breakthrough method boosts stem cells’ ability to share mitochondria, offering hope for treating aging, heart disease and neurodegenerative disorders by restoring cellular energy.

Biomedical engineering researchers are exploring a novel treatment for alcohol-related liver disease using nanoparticles a thousand times smaller than a human hair.

A sweetener commonly found in chewing gum can replace toxic additives in hydrogels used to diagnose and treat a variety of medical conditions.

In a new study, Texas A&M researchers have used a skin-like material as a platform for investigating infections from intravenous catheters.

The new study, a collaboration involving pigs, aims to advance skin cancer treatment for both humans and animals.

Researchers have received $12.9 million from the DOD for a project with potential to vastly improve the way diseases are monitored.

Biomedical engineer Dr. Melissa Grunlan has received a grant to further her work developing this cost-saving device.

Vessel-chip technology may offer more personalized pharmaceutical drug testing, leading to our improved ability to combat disease.